L.F. Mausner

2.1k total citations
78 papers, 1.5k citations indexed

About

L.F. Mausner is a scholar working on Radiology, Nuclear Medicine and Imaging, Radiation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L.F. Mausner has authored 78 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Radiology, Nuclear Medicine and Imaging, 34 papers in Radiation and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L.F. Mausner's work include Radiopharmaceutical Chemistry and Applications (54 papers), Nuclear Physics and Applications (18 papers) and Medical Imaging Techniques and Applications (16 papers). L.F. Mausner is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (54 papers), Nuclear Physics and Applications (18 papers) and Medical Imaging Techniques and Applications (16 papers). L.F. Mausner collaborates with scholars based in United States, United Kingdom and Japan. L.F. Mausner's co-authors include S.C. Srivastava, K. L. Kolsky, Vishwas N. Joshi, Saed Mirzadeh, G.E. Meinken, Dmitri Medvedev, R. A. Naumann, Jonathan Fitzsimmons, Amitava DasGupta and R.W. Stoenner and has published in prestigious journals such as Physical Review Letters, Cancer and Radiology.

In The Last Decade

L.F. Mausner

76 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.F. Mausner United States 23 1.1k 480 475 165 160 78 1.5k
Michael E. Fassbender United States 22 956 0.9× 426 0.9× 406 0.9× 191 1.2× 175 1.1× 63 1.4k
Férid Haddad France 26 1.0k 1.0× 554 1.2× 472 1.0× 219 1.3× 262 1.6× 144 1.9k
G.J. Beyer Germany 17 611 0.6× 228 0.5× 242 0.5× 135 0.8× 104 0.7× 54 967
Christiaan Vermeulen South Africa 18 737 0.7× 323 0.7× 326 0.7× 120 0.7× 164 1.0× 58 1.0k
Β. Schölten Germany 21 1.1k 1.0× 673 1.4× 337 0.7× 194 1.2× 295 1.8× 62 1.5k
F.M. Nortier United States 26 1.2k 1.2× 895 1.9× 479 1.0× 321 1.9× 508 3.2× 84 2.1k
F. Szelecsényi Hungary 25 1.3k 1.2× 953 2.0× 335 0.7× 274 1.7× 484 3.0× 80 1.8k
R. E. Shefer United States 17 721 0.7× 310 0.6× 285 0.6× 106 0.6× 180 1.1× 50 1.3k
T. N. van der Walt South Africa 17 524 0.5× 303 0.6× 176 0.4× 95 0.6× 124 0.8× 61 883
R. Weinreich Switzerland 20 613 0.6× 391 0.8× 169 0.4× 121 0.7× 134 0.8× 52 1.2k

Countries citing papers authored by L.F. Mausner

Since Specialization
Citations

This map shows the geographic impact of L.F. Mausner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.F. Mausner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.F. Mausner more than expected).

Fields of papers citing papers by L.F. Mausner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.F. Mausner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.F. Mausner. The network helps show where L.F. Mausner may publish in the future.

Co-authorship network of co-authors of L.F. Mausner

This figure shows the co-authorship network connecting the top 25 collaborators of L.F. Mausner. A scholar is included among the top collaborators of L.F. Mausner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.F. Mausner. L.F. Mausner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mausner, L.F.. (2023). In vivo generator for radioimmunotherapy. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information).
2.
Fitzsimmons, Jonathan, et al.. (2019). Optimization of Cation Exchange for the Separation of Actinium-225 from Radioactive Thorium, Radium-223 and Other Metals. Molecules. 24(10). 1921–1921. 10 indexed citations
3.
Radchenko, Valery, Jonathan W. Engle, Dmitri Medvedev, et al.. (2017). Proton-induced production and radiochemical isolation of 44Ti from scandium metal targets for 44Ti/44Sc generator development. Nuclear Medicine and Biology. 50. 25–32. 25 indexed citations
4.
Medvedev, Dmitri, Jonathan W. Engle, Roy Copping, et al.. (2016). Large scale accelerator production of 225Ac: Effective cross sections for 78–192 MeV protons incident on 232Th targets. Applied Radiation and Isotopes. 118. 366–374. 82 indexed citations
5.
Fitzsimmons, Jonathan & L.F. Mausner. (2015). Production scale purification of Ge-68 and Zn-65 from irradiated gallium metal. Applied Radiation and Isotopes. 101. 60–64. 11 indexed citations
6.
Medvedev, Dmitri, L.F. Mausner, & P.H. Pile. (2015). Tailoring medium energy proton beam to induce low energy nuclear reactions in 86SrCl2 for production of PET radioisotope 86Y. Applied Radiation and Isotopes. 101. 20–26. 3 indexed citations
7.
Medvedev, Dmitri, et al.. (2011). Development of a large scale production of 67Cu from 68Zn at the high energy proton accelerator: Closing the 68Zn cycle. Applied Radiation and Isotopes. 70(3). 423–429. 51 indexed citations
8.
Mausner, L.F., K. L. Kolsky, Vishwas N. Joshi, & S.C. Srivastava. (1998). Radionuclide development at BNL for nuclear medicine therapy. Applied Radiation and Isotopes. 49(4). 285–294. 109 indexed citations
9.
Kolsky, K. L., Vishwas N. Joshi, L.F. Mausner, & S.C. Srivastava. (1998). Radiochemical purification of no-carrier-added scandium-47 for radioimmunotherapy. Applied Radiation and Isotopes. 49(12). 1541–1549. 82 indexed citations
10.
Srivastava, S.C., H.L. Atkins, Gerbail T. Krishnamurthy, et al.. (1998). Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study.. PubMed. 4(1). 61–8. 62 indexed citations
11.
DeNardo, Gerald L., David L. Kukis, Sally J. DeNardo, et al.. (1997). Enhancement of67Cu-2IT-BAT-LYM-1 therapy in mice with human burkitt's lymphoma (Raji) using interleukin-2. Cancer. 80(S12). 2576–2582. 8 indexed citations
12.
Mausner, L.F., Vishwas N. Joshi, & K. L. Kolsky. (1995). Evaluation of chelating agents for radioimmunotherapy with scandium-47. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 36(6). 857–61. 14 indexed citations
13.
Mausner, L.F., S.C. Srivastava, K. L. Kolsky, et al.. (1994). Development and evaluation of copper-67 labeled DOTA and TETA immunoconjugates for radioimmunotherapy. Journal of Labelled Compounds and Radiopharmaceuticals. 35. 374–376. 3 indexed citations
14.
Srivastava, S.C., L.F. Mausner, K. L. Kolsky, et al.. (1994). Production and use of cobalt-55 as an antibody label for PET imaging. Journal of Labelled Compounds and Radiopharmaceuticals. 35. 389–391. 5 indexed citations
15.
Atkins, H.L., L.F. Mausner, S.C. Srivastava, et al.. (1993). Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful osseous metastases.. Radiology. 186(1). 279–283. 42 indexed citations
16.
Mausner, L.F. & S.C. Srivastava. (1993). Selection of radionuclides for radioimmunotherapy. Medical Physics. 20(2). 503–509. 82 indexed citations
17.
Kolsky, K. L. & L.F. Mausner. (1993). Production of no-carrier-added 199Au for gold cluster-labelled antibodies. Applied Radiation and Isotopes. 44(3). 553–560. 12 indexed citations
18.
Srivastava, S.C., L.F. Mausner, & Ronnie C. Mease. (1991). Criteria for the selection of radionuclides for tumor radioimmunotherapy. University of North Texas Digital Library (University of North Texas). 2 indexed citations
19.
Hainfeld, James F., S.C. Srivastava, L.F. Mausner, et al.. (1990). Radioactive gold cluster immunoconjugates: Potential agents for cancer therapy. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 17(3). 287–294. 12 indexed citations
20.
Zanzi, I., S.C. Srivastava, G.E. Meinken, et al.. (1989). A new cholescintigraphic agent: Ruthenium-97-DISIDA. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 16(4). 397–403. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael E. Fassbender Breakdown of academic impact, for papers by Férid Haddad Breakdown of academic impact, for papers by G.J. Beyer Breakdown of academic impact, for papers by Christiaan Vermeulen Breakdown of academic impact, for papers by Β. Schölten Breakdown of academic impact, for papers by F.M. Nortier Breakdown of academic impact, for papers by F. Szelecsényi Breakdown of academic impact, for papers by R. E. Shefer Breakdown of academic impact, for papers by T. N. van der Walt Breakdown of academic impact, for papers by R. Weinreich
Rankless by CCL
2026